ALDX
#3972
Aldeyra Therapeutics, Inc. - Common Stock
1.4 9 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.68%
Variación mensual
-3.87%
Variación en los últimos 6 meses
-72.41%
Cambio anual
-74.40%
Cierres anteriores
1.4 8
Open
1.4 9
Mínimo
1.4 7
Máximo
1.5 0
Volumen
159
Financials
- Market Capitalization 89.89 M
- Employee 6
- Founded 2004
- CEO Todd C. Brady M.D., Ph.D.
- Website www.aldeyra.com
- Headquarter Delaware, United States
- FIGI BBG0029H8ZF6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.61
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3970 |  ICCC ImmuCell Corporation - Common Stock | 9.92 USD | +1.33% | +0.71% | -12.44% | +57.71% | 90.10 M USD | ||
| 3971 |  RLYB Rallybio Corporation - Common Stock | 16.69 USD | -0.60% | -1.53% | +4.57% | +3109.62% | 88.63 M USD | ||
| 3978 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.08 USD | -0.48% | -4.59% | +36.84% | +58.78% | 89.13 M USD | ||
| 3989 |  ACET Adicet Bio, Inc. - Common Stock | 9.40 USD | +8.05% | +4.44% | +2.29% | +1187.67% | 88.00 M USD |